Intuitive reports Q3 revenue $3.05B, GAAP EPS $1.49 and non-GAAP EPS $3.00
Intuitive Surgical reported Q3 2026 revenue of $3.05B, up 22% YoY, with GAAP EPS $1.49 and non-GAAP EPS $3.00. The results included a $450M litigation charge and a $22M tariff refund benefit. The company ended the quarter with $6.80B in cash and repurchased 7.8M shares for $2.94B. Procedure growth was 15% YoY, with da Vinci systems up 12% and Ion systems up 21%.
How this was made
The 30-second read
Why it matters
Earnings beat and large buyback reinforce growth narrative, likely supporting the stock.
Market read
The earnings release provides fresh material for traders to consider positioning in ISRG.
What to watch
The $22M tariff refund is a one-time benefit and may not repeat.
Background
Intuitive Surgical is a leading provider of robotic surgical systems, recently expanding its da Vinci and Ion platforms.
Ticker impact
Intuitive Surgical reported Q3 2026 revenue of $3.05B, GAAP EPS $1.49 and announced a $2.94B share repurchase.
likely upside as market prices in earnings beat and share repurchase.
Revenue grew 22% YoY, EPS beat expectations, and a $2.94B buyback signals confidence.
Market effects
Positive earnings may lift the broader medical device and robotic surgery sector.
U.S. market may see modest gains in healthcare stocks.
Limited to investors tracking U.S. healthcare equities.
Counterpoint
If the litigation charge signals future legal risk, the stock could face downside.
Key entities
- companyIntuitive Surgical Inc.
Manufacturer of da Vinci and Ion surgical robots.
